WaveMan
WaveMan · Company
PSNL · Personalis, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

PSNL Personalis (PSNL) Insider Trading, Ownership & Congress Trades

Healthcare Services · Services-medical laboratories · CIK 0001527753
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
111
13F, latest reported quarter
Conversions, 180 days
10
Codes C/M, not in net · $1.9M priced

What the filings say about PSNL

Insiders, 180 days
-$7.4M net sold
4 sellers · 0% of sales under a 10b5-1 plan

Personalis insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Personalis, Inc. insiders sold a net $7.4M of stock across 130 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Moore Stephen Michael
SVP and Chief Legal Officer
SELL
2026-09-22 SECtraded 2026-09-18
2,068
$33.5K
-2.9%
Context
  • 16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on May 16, 2025.
  • The trade is 2.3% of the 90,257 shares held after it.
  • 3 other insiders sold within 30 days.
  • 111 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP and Chief Legal Officer Moore Stephen Michael sold about $33.5K of PSNL on Sep 18, 2026; 3 other insiders sold within 30 days and 111 funds added in the latest 13F quarter.
Chen Richard
President and CMO
SELL
2026-09-22 SECtraded 2026-09-18
3,998
$64.8K
-2.9%
Context
  • 36 earlier Form 4 trades (code P or S) here by this insider (36 sales), the last on Jul 15, 2026.
  • The trade is 2.4% of the 169,882 shares held after it.
  • 3 other insiders sold within 30 days.
  • 111 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CMO Chen Richard sold about $64.8K of PSNL on Sep 18, 2026; 3 other insiders sold within 30 days and 111 funds added in the latest 13F quarter.
Hall Christopher M
Chief Executive Officer
SELL
2026-09-22 SECtraded 2026-09-18
7,459
$121.0K
-2.9%
Context
  • 7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Jul 9, 2026.
  • The trade is 3.3% of the 228,527 shares held after it.
  • 3 other insiders sold within 30 days.
  • 111 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Hall Christopher M sold about $121.0K of PSNL on Sep 18, 2026; 3 other insiders sold within 30 days and 111 funds added in the latest 13F quarter.
Tachibana Aaron
CFO AND COO
SELL
2026-09-22 SECtraded 2026-09-18
2,931
$47.5K
-2.9%
Context
  • 40 earlier Form 4 trades (code P or S) here by this insider (40 sales), the last on Jun 29, 2026.
  • The trade is 1.5% of the 195,902 shares held after it.
  • 3 other insiders sold within 30 days.
  • 111 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO AND COO Tachibana Aaron sold about $47.5K of PSNL on Sep 18, 2026; 3 other insiders sold within 30 days and 111 funds added in the latest 13F quarter.
Chen Richard
President and CMO
SELL
2026-07-15 SEC
100,000
$1.5M
+1.9%
Context
  • 35 earlier Form 4 trades (code P or S) here by this insider (35 sales), the last on Jul 28, 2025.
  • The trade is 57.5% of the 173,880 shares held after it.
  • 2 other insiders sold within 30 days.
  • 111 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CMO Chen Richard sold about $1.5M of PSNL on Jul 15, 2026, the largest insider sale at the company since 2021; 2 other insiders sold within 30 days and 111 funds added in the latest 13F quarter.
130 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 125 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$7.4M over 180 days
-$266.9K over 90 days
below 60% of Healthcare Services
Congress
no House purchase disclosed in the last 12 months
Funds
111 funds bought in last quarter
below 54% of Healthcare Services
Revenue
-17.7% year over year
below 88% of Healthcare Services
Margin
-116.7% net margin
below 94% of Healthcare Services
Buybacks
no share repurchases reported
Short interest
9.8% of the float short (float per yahoo 2026-10-26) · 4.3 days to cover · settled 2026-09-30
more than 78% of Healthcare Services
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch PSNL

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+68.0%12M
-47%+0%+47%+94%2025-102025-122026-022026-042026-062026-082026-10 2026-07-15 · Chen Richard sold $1.5M2026-07-09 · Hall Christopher M sold $1.5M2026-06-26 · Hall Christopher M sold $1.3M2025-11-25 · Tachibana Aaron sold $1.1M2026-05-29 · Hall Christopher M sold $882.6K2026-06-26 · Tachibana Aaron sold $675.5K2025-11-18 · Tempus AI, Inc. bought $496.6K2026-06-04 · Tachibana Aaron sold $480.4K2026-05-29 · Tachibana Aaron sold $449.3K2025-11-03 · Hall Christopher M sold $266.2K2025-12-22 · Tempus AI, Inc. bought $250.0K2025-11-24 · Tempus AI, Inc. bought $249.0K2025-11-19 · Tempus AI, Inc. bought $248.8K2025-11-20 · Tempus AI, Inc. bought $248.8K2025-12-17 · Tempus AI, Inc. bought $248.8K2025-12-19 · Tempus AI, Inc. bought $248.7K2025-12-18 · Tempus AI, Inc. bought $248.6K2026-05-28 · Hall Christopher M sold $219.4K2025-11-21 · Tempus AI, Inc. bought $161.7K2025-11-25 · Tempus AI, Inc. bought $152.8K2026-09-18 · Hall Christopher M sold $121.0K2025-11-25 · Tempus AI, Inc. bought $97.9K2025-11-21 · Tempus AI, Inc. bought $87.5K2026-06-29 · Tachibana Aaron sold $69.7K2026-09-18 · Chen Richard sold $64.8K2026-09-18 · Tachibana Aaron sold $47.5K2026-09-18 · Moore Stephen Michael sold $33.5K2026-01-22 · Tachibana Aaron sold $13.8K2026-07-15 · RICHARD CHEN filed to sell $1.5M2026-07-09 · Chris Hall filed to sell $1.4M2026-06-29 · AARON TACHIBANA filed to sell $64.9K2026-06-26 · Chris Hall filed to sell $1.3M2026-06-26 · AARON TACHIBANA filed to sell $645.3K
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns PSNL: institutional holders (13F)

13F holdings, latest reported quarter
Merck & Co., Inc.
14,044,943 sh
$188.2M
ARK Investment Management LLC
8,271,339 sh
$110.8M
BlackRock, Inc.
7,082,491 sh
$94.9M
LIGHTSPEED MANAGEMENT COMPANY, L.L.C.
6,101,850 sh
$81.8M
AMERIPRISE FINANCIAL INC
6,086,315 sh
$81.6M

Congress trades in PSNL

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

PSNL planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
RICHARD CHEN
Filed 2026-07-15
$1.5M
Chris Hall
Filed 2026-07-09
$1.4M
AARON TACHIBANA
Filed 2026-06-29
$64.9K
Chris Hall
Filed 2026-06-26
$1.3M
AARON TACHIBANA
Filed 2026-06-26
$645.3K

PSNL mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
ARK Genomic Revolution ETF
$85.3M position · as of 2026-07-31
5.5%
AlphaCentric Life Sciences and Healthcare Fund
$1.1M position · as of 2026-06-30
2.3%
iShares Genomics Immunology and Healthcare ETF
$1.7M position · as of 2026-07-31
0.9%
BRUCE FUND
$3.1M position · as of 2026-06-30
0.8%
Global X Genomics & Biotechnology ETF
$438.6K position · as of 2026-05-31
0.8%
NORTH SQUARE KENNEDY MICROCAP FUND
$233.1K position · as of 2026-05-31
0.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Government contracts
Award ceilings over the contract's life, subsidiaries included. Not annual revenue (USASpending.gov).
Department Of Veterans Affairs
EO 14398 · 2026-09-30
$18.3M
Federal awards ≥ $25M in the last 90 days, matched via the SAM.gov parent registry
Executive pay vs shareholder return · Christopher Hall
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$1.5M
$4.4M
$1.0M
+192%
n/a
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $7.4M sold by insiders over 180 days, 111 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHADUSSERABDSX

PSNL financials

Revenue growth
-17.7%
XBRL, annual
Net margin
-116.7%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$69.7M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-153.8%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$101.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.08x
long-term 2019-06-30 (85 months older than the period end) plus current 2019-06-30 (85 months older than the period end); equity 2026-06-30
Cash flow to debt
-4.85x
TTM operating cash flow over long-term 2019-06-30 (85 months older than the period end) plus current 2019-06-30 (85 months older than the period end)
Return on equity
-50.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-37.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
-46.4%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$1.6B
market value at close 2026-10-26 on 2026-07-29 shares, plus long-term 2019-06-30 (85 months older than the period end) plus current 2019-06-30 (85 months older than the period end), minus cash 2026-06-30
FCF yield
-6.0%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$69.6M$84.6M$73.5M$65.0M
Operating income-$88.1M-$68.3M-$109.9M-$115.5M
Net income-$81.3M-$81.3M-$108.3M-$113.3M
EPS (diluted)-0.91-1.37-2.25-2.48
Operating cash flow-$74.9M-$45.1M-$56.3M-$70.2M
Cash$124.2M$91.4M$57.0M$89.1M
SEC XBRL, fiscal years, as known on 2026-10-28

PSNL Stock Sonar score 6/7 axes

Find similar shapesCompare

PSNL ranks highest on financial health (42nd percentile) and institutional and government (38th), and lowest on growth (12th), among Healthcare Services peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
20
Inputs
  • Return on equity-50.3% · 23 pct, sector of 70
  • Return on assets-37.6% · 21 pct, sector of 88
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed-46.4% · 15 pct, sector of 68
Financial health
42
Inputs
  • Debt to equity0.08x · 73 pct, sector of 61
  • Cash flow to debt-4.85x · 11 pct, sector of 66
Growth
12
Inputs
  • Revenue growth, YoY-17.7% · 12 pct, sector of 87
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
16
Inputs
  • Net Form 4 buying (codes P and S), 180d-$7.4M · 32 pct, sector of 64
  • Insider buyers, 180d0 · 0 pct, sector of 64
Institutional and government
38
Inputs
  • Funds adding, latest quarter111 · 46 pct, sector of 73
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180d$18.3M · 38 pct, universe of 69
  • Lobbying spend, 4 quarters$200K · 30 pct, universe of 1,063
Risk and compliance
33
Inputs
  • Short interest, % of float+9.8% · 27 pct, sector of 95
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+11.6% · 39 pct, sector of 72
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

PSNL filings, in plain words

Are Personalis insiders buying or selling PSNL?

In the 180 days to 2026-10-28, Personalis insiders were net sellers, a net $7.4M across purchases and sales reported on Form 4, by 4 sellers.

Read the full summary

In the 180 days to 2026-10-28, Personalis insiders were net sellers of PSNL, a net $7.4M across purchases and sales reported on Form 4 by 4 sellers. None of the 13 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies